NNVC NanoViricides Inc
P/E
--
Forward P/E
--
Price/Sales
--
Beta
1.791
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🔴 NNVC is trading 8.2% down today, extending a pullback after a strong multi-month run
NNVC is trading 8.2% down at $1.24 in pre-market, extending a mild pullback after a strong multi-month run and recent high volatility. • No fresh...
NanoViricides Gets an FDA Gold Star for Its Measles Drug — But Can a Seven-Person Company Actually Deliver a $100M-Plus Payday?
Shares of NanoViricides slid 11.2% to $1.22 in pre-market trading on June 30, pulling back sharply after a week-long rally triggered by back-to-back regulatory...
🔴 NNVC is trading 11.2% down today as traders reassess rally following FDA rare pediatric designation
NNVC is trading 11.2% down at $1.22 in pre-market, pulling back after a sharp recent advance following news that the FDA granted Rare Pediatric Disease Drug...
NanoViricides Wins FDA Pediatric Status for Measles Drug, Eligible for $100M Voucher
NanoViricides Inc. (NNVC) received U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Drug (RPDD) designation for its antiviral drug NV-387. This...